| Advances in cancer immunotherapy 2019–latest trends S Kruger, M Ilmer, S Kobold, BL Cadilha, S Endres, S Ormanns, ... Journal of Experimental & Clinical Cancer Research 38, 1-11, 2019 | 521 | 2019 |
| Interleukins in cancer: from biology to therapy D Briukhovetska, J Dörr, S Endres, P Libby, CA Dinarello, S Kobold Nature Reviews Cancer 21 (8), 481-499, 2021 | 410 | 2021 |
| Killing mechanisms of chimeric antigen receptor (CAR) T cells MR Benmebarek, CH Karches, BL Cadilha, S Lesch, S Endres, S Kobold International journal of molecular sciences 20 (6), 1283, 2019 | 401 | 2019 |
| Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity L Ferrari de Andrade, RE Tay, D Pan, AM Luoma, Y Ito, S Badrinath, ... Science 359 (6383), 1537-1542, 2018 | 383 | 2018 |
| Teaching an old dog new tricks: next-generation CAR T cells N Tokarew, J Ogonek, S Endres, M von Bergwelt-Baildon, S Kobold British journal of cancer 120 (1), 26-37, 2019 | 353 | 2019 |
| CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment M Di Pilato, R Kfuri-Rubens, JN Pruessmann, AJ Ozga, M Messemaker, ... Cell 184 (17), 4512-4530. e22, 2021 | 220 | 2021 |
| RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells P Duewell, A Steger, H Lohr, H Bourhis, H Hoelz, SV Kirchleitner, ... Cell Death & Differentiation 21 (12), 1825-1837, 2014 | 198 | 2014 |
| Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis X Liu, J Li, BL Cadilha, A Markota, C Voigt, Z Huang, PP Lin, DD Wang, ... Science advances 5 (6), eaav4275, 2019 | 179 | 2019 |
| Limitations in the design of chimeric antigen receptors for cancer therapy S Stoiber, BL Cadilha, MR Benmebarek, S Lesch, S Endres, S Kobold Cells 8 (5), 472, 2019 | 163 | 2019 |
| Toll-like receptor 4–induced IL-22 accelerates kidney regeneration OP Kulkarni, I Hartter, SR Mulay, J Hagemann, MN Darisipudi, SK Vr, ... Journal of the American Society of Nephrology 25 (5), 978-989, 2014 | 152 | 2014 |
| Impact of a new fusion receptor on PD-1–mediated immunosuppression in adoptive T cell therapy S Kobold, S Grassmann, M Chaloupka, C Lampert, S Wenk, F Kraus, ... Journal of the National Cancer Institute 107 (8), djv146, 2015 | 137 | 2015 |
| Cancer cells induce interleukin-22 production from memory CD4+ T cells via interleukin-1 to promote tumor growth C Voigt, P May, A Gottschlich, A Markota, D Wenk, I Gerlach, S Voigt, ... Proceedings of the National Academy of Sciences 114 (49), 12994-12999, 2017 | 136 | 2017 |
| Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology P Libby, S Kobold Cardiovascular research 115 (5), 824-829, 2019 | 134 | 2019 |
| Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites? S Kobold, S Hegewisch-Becker, K Oechsle, K Jordan, C Bokemeyer, ... The oncologist 14 (12), 1242-1251, 2009 | 133 | 2009 |
| Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells D Atanackovic, Y Hildebrandt, A Jadczak, Y Cao, T Luetkens, S Meyer, ... Haematologica 95 (5), 785, 2010 | 130 | 2010 |
| Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells D Atanackovic, Y Hildebrandt, A Jadczak, Y Cao, T Luetkens, S Meyer, ... Haematologica 95 (5), 785, 2010 | 130 | 2010 |
| Melanoma models for the next generation of therapies EE Patton, KL Mueller, DJ Adams, N Anandasabapathy, AE Aplin, ... Cancer cell 39 (5), 610-631, 2021 | 111 | 2021 |
| Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR D Stenger, TA Stief, T Kaeuferle, S Willier, F Rataj, K Schober, B Vick, ... Blood, The Journal of the American Society of Hematology 136 (12), 1407-1418, 2020 | 110 | 2020 |
| Enhancing tumor T cell infiltration to enable cancer immunotherapy J Zhang, S Endres, S Kobold Immunotherapy 11 (3), 201-213, 2019 | 110 | 2019 |
| The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients Y Cao, T Luetkens, S Kobold, Y Hildebrandt, M Gordic, N Lajmi, S Meyer, ... Experimental hematology 38 (10), 860-867, 2010 | 104 | 2010 |
